Thread by @HadidiSamer on Thread Reader App
@HadidiSamer: #mmsm How to counsel patients about Cilta Cel using the data from CARTITUDE-4 and FDA ODAC meeting for earlier use With data of Cilta cel and Ide cel, assuming having access to both for a……
@HadidiSamer: #mmsm How to counsel patients about Cilta Cel using the data from CARTITUDE-4 and FDA ODAC meeting for earlier use With data of Cilta cel and Ide cel, assuming having access to both for a……
Mayo Clinic’s PragMMatic Study Accruing Newly Diagnosed Multiple Myeloma Patients A new clinical trial administered by the Mayo Clinic, the PragMMatic Study, is now accruing newly…
TPS9605 Background: Adjuvant treatment with anti-PD1 therapy improves the recurrence free survival (RFS) in resectable stage III melanoma. The Checkmate-238 and KEYNOTE-054 trials respectively reported…
FDA-AACR Workshop: How Much is Enough? Trial Designs for Treatment Regimens with Multiple Phases Date: May 9, 2024 | 9:00 a.m. – 4:00 p.m. Location:…
The OncoAlert Newsletter is now out for June 23-29, 2023
In a pair of Special Reports, Gökbuget and colleagues present updated European Leukemia Net (ELN) consensus reports on (1) the diagnosis, prognostic factor
‘Boring Milner’ and ‘Andy Robson’ accounts work with Fanwave Digital, a firm paid by Paddy Power Betfair to post betting tips
Many parents and policymakers view the belief that social media use is harmful for youth to be common sense. But is it?
A decision by the drug manufacturer Moderna to drop plans to set up its first mRNA vaccine manufacturing plant outside the United States in Nairobi,…
Excuse my Japanese language skills,
This article reports a series of patients with metastatic solid tumors treated with immune checkpoint blockade, focusing on associations between immune-related